COMMUNIQUÉS West-GlobeNewswire

Spectral AI, Inc. Announces Return of Founder Dr. J. Michael DiMaio as Chairman of the Board of Directors
14/10/2024
DALLAS, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial
14/10/2024
The study found improvements in reading speed, vision-related quality of life, and suggested potential benefits of an interventional approach for patients with dry eye disease MENLO PARK, Calif., Oct. 14, 2024 (GLOBE [...]
The Association of American Physicians and Surgeons (AAPS) Sues to Block Expansion of the Federal Police State
14/10/2024
TUCSON, Ariz., Oct. 14, 2024 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (“AAPS”) served a lawsuit on Oct 11, seeking to block the upcoming requirement that tens of millions Americans provide [...]
Inventiva announces the availability of a prospectus in connection with its financing through the issuance of ordinary shares and pre-funded warrants
14/10/2024
Daix (France), Long Island City (New York, United States), October 14, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the [...]
Inventiva annonce la mise à disposition d'un prospectus dans le cadre de son financement par l’émission d’actions ordinaires et de bons de souscription d’action préfinancés
14/10/2024
Daix (France), Long Island City (New York, États-Unis), le 14 octobre 2024 – Inventiva (Euronext Paris et Nasdaq: IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement [...]
Norton Healthcare acquires groundbreaking focused ultrasound technology
14/10/2024
Norton Neuroscience Institute first in Kentucky with incisionless surgery for essential tremor, tremor-dominant Parkinson’s disease LOUISVILLE, Ky., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Norton Neuroscience Institute is the [...]
Ipsen receives its second Shingo Prize for operational excellence
14/10/2024
Ipsen is the first pharma company in the world to receive Shingo Prizes for two sites producing treatments for patients Ipsen’s first Shingo Prize was received by its production site in Signes, France in 2020, followed [...]
Ipsen reçoit un deuxième prix Shingo pour son excellence opérationnelle
14/10/2024
Ipsen est la première société pharmaceutique au monde à avoir reçu le prix Shingo pour deux sites de production de médicaments destinés aux patients. Ipsen a reçu son premier prix Shingo pour son site de production de [...]
Psyence Group Enters into Debt-for-Equity Swap Agreement with its NASDAQ-Listed Associate, Psyence Biomedical
14/10/2024
TORONTO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (" Psyence Group " or the " Company ") (CSE: PSYG) hereby announces that it has entered into a debt-for-equity swap agreement (the " Debt Swap Agreement ") [...]
Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)
14/10/2024
First Phase 3 PDT study in patients with sBCC in the United States. Rigorous dual endpoints requiring complete clinical and cytological clearance of malignant lesions. Data now being analyzed, interim results expected [...]
Cookie Diet announces the launch of new Four-Week Program
14/10/2024
America's most convenient diet revealed: These famous weight-loss cookies make it easy to shred kilos AND there’s a money-back guarantee. SYDNEY, Australia, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Dr Siegal’s famous Cookie [...]
Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology
14/10/2024
PONTE VEDRA, Fla., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
You’re Invited! WonderTree’s Innovative, Team-Based Clinic to Celebrate Grand Opening
14/10/2024
On Friday, October 18, WonderTree will be showcasing its model for child and adolescent mental healthcare WonderTree founders Dr. Stephanie Lavoie (left) and Dr. Michelle Fardella (right) ORANGEVILLE, Ontario, Oct. 14, [...]
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)
14/10/2024
Combined company to expand portfolio of clinical & commercial-stage assets in fertility, oncology, and autoimmune diseases SARASOTA, Fla. and MIAMI, Oct. 14, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience (“INVO”) (NASDAQ [...]
Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)
14/10/2024
MIAMI, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that its submission entitled “Lomecel-B inhibition of [...]
TytoCare and Frontier Health Partner to Provide Virtual-First Primary Care to Individuals and Employees across the United States
14/10/2024
New Partnership Will Provide TytoCare Devices to Thousands of Frontier Members across the U.S., Enabling In-Home Diagnostics and Extending Convenient Access to Relationship-Based Primary Care NEW YORK, Oct. 14, 2024 ( [...]
NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression
14/10/2024
Data selected for oral presentation reinforce previous findings on safety and efficacy MALVERN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing [...]
Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs
14/10/2024
Veteran medical device executive to drive regulatory and clinical strategy as Nexalin advances drug-free Deep Intracranial Frequency Stimulation (DIFS) technology for mental health treatment HOUSTON, TX, Oct. 14, 2024 ( [...]
Aprea Therapeutics to Present at Maxim 2024 Healthcare Virtual Summit
14/10/2024
DOYLESTOWN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic [...]

Pages